Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. - Wikidata - awgldk - TriplyDB

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

http://www.wikidata.org/entity/Q35119049

about

Severe community-acquired meningitis.The place of quinolones in paediatric anti-infective therapy Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan.Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children wit Antibiotic susceptibility patterns of Streptococcus pneumoniae in china and comparison of MICs by agar dilution and E-test methods.Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis Dexamethasone in bacterial meningitis: to use or not to use?Impact of antimicrobial agents and chemotherapy from 1972 to 1998.Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically ac Dissemination of Streptococcus pneumoniae clone Colombia(5)-19 in Latin America.The emergence of resistant pneumococcal meningitis--implications for empiric therapy.Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolated in Algiers, Algeria Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network.Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococci Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin.High mortality among patients with bacterial meningitis in a rural hospital in Tanzania.Meningitis in a Canadian adult due to high level penicillin-resistant, cefotaxime-intermediate Streptococcus pneumoniae.Acute bacterial meningitis in infants and children: epidemiology and management.Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis Bacterial resistance and the dilemma of antibiotic usage.Efficacy of telavancin against penicillin-resistant pneumococci and Staphylococcus aureus in a rabbit meningitis model and determination of kinetic parameters.Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone.Controlling antibiotic resistance by quelling the epidemic of overuse and misuse of antibiotics.Drug not considered a first-line agent.Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults.Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance.An update on invasive pneumococcal antibiotic resistance in Turkey, 2008.Prevalence of penicillin non-susceptible invasive pneumococcal disease in the elderly in Scotland, 1992-99.Prevention of Pneumococcal Meningitis.Austrian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae 1994-96.

P2860

Q24795217-E80DFCBF-CC83-4A9D-823D-A24837ED64F0 Q33583442-44B10FE3-3AC9-4652-B52A-858BE9B55969 Q33672446-7B9E8C32-F691-4C9B-8457-337FEAF7370D Q33692927-063B0A03-099D-4F25-A744-4A46DEE2C11A Q33699406-2528318E-5217-4902-8BA3-B75FE0F5CF88 Q33699541-05DC27FF-A5B3-4CBB-BB76-84226C3A1A04 Q33929287-9F4F57B6-3395-417D-8C50-F7E09D739B37 Q33970709-F6E4CD6C-3676-4C5B-83E0-1E56F03CC6EE Q33977786-75889739-F279-491E-90C1-40D3FF047DCF Q34439767-5F92FA61-F826-4516-9781-6141E79424D2 Q34794716-C74A3CDA-10BF-4859-A2FC-0B39DFB47EA1 Q34824189-017C25F3-9FBF-4335-A2BD-7DD9F610A0C9 Q35126435-4E246D52-1B2B-444A-884D-A2AE1E68CA04 Q35127137-52FBFC93-ABE7-4E21-A2DD-C67B9A25E8DE Q35129463-4AE136C5-796B-4B83-87E9-70A96B06C256 Q35138302-4BEFAA6F-12E6-4ECA-9CA3-03E9868CEE97 Q35138311-63F31744-8058-4E94-A910-F57C7EB6CC1C Q35761392-67482AA7-F7A4-4A11-9FD5-B59E945E1FBE Q35891448-68AC3BFF-96DA-471A-BB58-EB6CA6DC099A Q37945754-75FA6635-3113-4719-9943-A260C26E7177 Q39781217-BD9B6F56-A016-43F3-9CEB-2733B7EE5790 Q39784239-A98E751A-B2B8-46B2-883A-4D609B187F8D Q39785256-6A07CA09-8CE4-481B-BC2B-BB7D46CC5E80 Q40283374-8292494C-AC08-40B4-9B6F-6BE3ECCD0E38 Q41831644-BA7C3AC3-6925-4F18-876A-7434D08A18EA Q41873974-C3145BE5-1B8D-47A5-8631-D04FE6699FC0 Q43091637-D124EA03-D413-4334-9906-F13515C21091 Q43091859-1F46172F-27F3-4417-8339-4D784796E098 Q44043634-831103D9-7DF3-4758-B693-8F3B1B1E84D5 Q44064229-5B05F28F-5653-4400-BF63-87CA62B3CC03 Q44183506-6EDBEF95-6CFF-43B3-8342-5DE02D17237C Q53958416-DF6A5199-4464-4BC6-BCDF-F6E018D572AE Q53964602-72B725E4-743B-4E18-B52A-5E206997AEE8 Q54116795-975394B6-D8CD-4130-B208-BFD97E4B8FB6

P2860

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

http://www.wikidata.org/entity/Q35119049

description

1995 nî lūn-bûn

@nan

1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

@ast

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

@en

type

label

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

@ast

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

@en

prefLabel

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

@ast

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

@en

P1433

Q35119049-E2CB0576-68E0-45CF-A3C4-5ABE16F1B4DA

P1476

Q35119049-77124862-E896-48A1-A75E-1E23CBB44591

P2093

Q35119049-08027008-8760-49EB-ABD8-0F5E13089B8F

Q35119049-243BF8F8-F409-403A-B435-8933FD11B642

Q35119049-5E48D056-F2DF-4275-81CD-A3946E6EE42C

P2860

Q35119049-02DA2B2A-11F4-4FAB-A4A5-1511AC6CA636

Q35119049-1365D498-DF6B-4022-92B3-4318044F7C6A

Q35119049-155D92C6-BED0-42D2-A719-406159FC2A31

Q35119049-24E17DA0-EBB5-4FF6-85B0-032ABCA4E32F

Q35119049-332AD0E2-D96B-4FA9-B47E-AA59A5C853B2

Q35119049-3615678C-5F59-4BA6-A7FD-E4ECBC17B3F8

Q35119049-3CD617C3-F22D-468B-BEDF-C445E3FCF8E6

Q35119049-40C672DE-2F3A-40FD-9667-7A5C0269E2AF

Q35119049-43592098-80BB-4D54-B7FA-F8A71C7E12C3

Q35119049-4AA8E00D-1E8E-4BFE-879A-7376B91A1B86

P304

Q35119049-0CF6BD3B-5B76-4477-8D25-B35BC4E80367

P31

Q35119049-B106DF06-AFE3-4413-AA15-F82FA6EE0B28

P356

Q35119049-DA75715B-1201-43D1-BCE0-E4F6FC889F0E

P407

Q35119049-F191FB23-B732-486D-81FD-8D82DC702084

P433

Q35119049-9EADC9D7-558B-4904-B8AD-AFE084FE6C4D

P478

Q35119049-F0A8FA0C-AF97-4A11-841D-7DE3214FEF81

P577

Q35119049-BA99D1DC-AE8E-42F0-B0EB-4EFDAA31A0F9

P698

Q35119049-DEC498EF-3C17-4A08-BA14-28EE0A2EF248

P921

Q35119049-282BF3B9-3456-405D-886F-64D3864743C0

P932

Q35119049-BD52CC12-A5B1-478B-8904-04C17A30F840

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

@en

P2093

McCracken GH Jr

http://www.w3.org/2001/XMLSchema#string

París MM

http://www.w3.org/2001/XMLSchema#string

Ramilo O

http://www.w3.org/2001/XMLSchema#string

P2860

Imipenem/cilastatin treatment of bacterial meningitis in children

Recurrent penicillin-resistant pneumococcal meningitis after chloramphenicol therapy

Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis.

Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis.

Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin.

Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials.

Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.

In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria.

Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

P304

2171-2175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.39.10.2171

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

1995-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8619561

http://www.w3.org/2001/XMLSchema#string

P921

P932

162908

http://www.w3.org/2001/XMLSchema#string